Express Scripts kicks another batch of meds off its preferred formulary

Vocal pharma-pricing critic Express Scripts ($ESRX) added almost 20 products to its list of excluded meds for 2016. With 80 drugs now ineligible for routine reimbursement, the pharmacy benefits manager says it has excluded about $1.3 billion worth of costs. The new National Preferred Formulary can apply to up to 25 million members. Report